{
    "Symbol": "DXCM",
    "AssetType": "Common Stock",
    "Name": "DexCom Inc",
    "Description": "DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.",
    "CIK": "1093557",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS",
    "Address": "6340 SEQUENCE DRIVE, SAN DIEGO, CA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "28972564000",
    "EBITDA": "886800000",
    "PERatio": "44.91",
    "PEGRatio": "1.335",
    "BookValue": "6.08",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "1.61",
    "RevenuePerShareTTM": "10.09",
    "ProfitMargin": "0.17",
    "OperatingMarginTTM": "0.157",
    "ReturnOnAssetsTTM": "0.0626",
    "ReturnOnEquityTTM": "0.294",
    "RevenueTTM": "3934800000",
    "GrossProfitTTM": "1883100000",
    "DilutedEPSTTM": "1.61",
    "QuarterlyEarningsGrowthYOY": "0.266",
    "QuarterlyRevenueGrowthYOY": "0.153",
    "AnalystTargetPrice": "102.4",
    "AnalystRatingStrongBuy": "13",
    "AnalystRatingBuy": "9",
    "AnalystRatingHold": "4",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "44.91",
    "ForwardPE": "41.67",
    "PriceToSalesRatioTTM": "7.36",
    "PriceToBookRatio": "11.58",
    "EVToRevenue": "7.03",
    "EVToEBITDA": "26.81",
    "Beta": "1.158",
    "52WeekHigh": "142",
    "52WeekLow": "62.34",
    "50DayMovingAverage": "111.08",
    "200DayMovingAverage": "117.93",
    "SharesOutstanding": "400727000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}